英伟达
NVDA
Adobe
ADBE
赛富时
CRM
苹果
AAPL
谷歌-C
GOOG
美股市场个股详情
PFE 辉瑞
- 26.360
- +0.590+2.29%
收盘价 12/20 16:00 (美东)
- 26.360
- 0.0000.00%
盘后 20:01 (美东)
1493.82亿总市值35.15市盈率TTM
26.490最高价25.700最低价1.16亿股成交量25.700今开25.770昨收30.62亿成交额2.06%换手率71.24市盈率(静)56.67亿总股本31.05752周最高1.62市净率1491.63亿流通值24.10552周最低1.67股息TTM56.59亿流通股53.878历史最高6.34%股息率TTM3.07%振幅5.393历史最低26.315平均价1股每手
关于辉瑞公司
辉瑞公司是一家以研究为基础的全球生物制药公司。它在全球范围内从事生物制药产品的发现、开发、制造、营销、销售和分销。该公司在发达市场和新兴市场开展业务，以促进健康、预防、治疗和治愈最可怕的疾病。
公司介绍
公司代码PFE
公司名称辉瑞
上市日期1944/01/17
成立日期1849
CEODr. Albert Bourla, D.V.M.,PhD
所属市场纽交所
员工数量88000
年结日12-31
公司地址66 Hudson Boulevard East
城市New York
省份纽约州
国家美国
邮编10001-2192
电话1-212-733-2323
董事高管
- 姓名
- 职务
- 年薪
- Dr. Albert Bourla, D.V.M.,PhD
- Chairman of the Board and Chief Executive Officer
- 2156.21万
- Michael McDermott
- Executive Vice President and Chief Global Supply Officer
- --
- Dr. Mikael Dolsten, M.D.,PhD
- Chief Scientific Officer and President, Pfizer Research and Development
- 885.87万
- Rady A. Johnson
- Chief Compliance, Quality and Risk Officer and Executive Vice President
- --
- Alexandre de Germay
- Chief International Commercial Officer and Executive Vice President
- --
- Dr. Chris Boshoff, M.D.,PhD
- Executive Vice President and Chief Oncology Officer
- --
- Lidia L. Fonseca
- Chief Digital and Technology Officer and Executive Vice President
- --
- David M. Denton
- Chief Financial Officer and Executive Vice President
- 527.95万
- Sally Susman
- Chief Corporate Affairs Officer and Executive Vice President
- --
- Aamir Malik
- Chief Commercial Officer, U.S. and Executive Vice President
- 542.07万
- Payal Sahni
- Chief People Experience Officer and Executive Vice President
- --
- Jennifer B. Damico
- Principal Accounting Officer, Senior Vice President and Controller
- --
- Margaret M. Madden
- Senior Vice President, Corporate Secretary and Chief Governance Counsel
- --
- Douglas M. Lankler
- Executive Vice President and General Counsel
- 547.78万
- Mortimer J. Buckley
- Director
- --
- Cyrus Taraporevala
- Director
- --
- Dr. Dan R. Littman, M.D.,PhD
- Independent Director
- 39.14万
- Suzanne Nora Johnson
- Independent Director
- 41.00万
- Dr. Susan J. Hockfield, PhD
- Independent Director
- 36.30万
- Dr. Helen H. Hobbs, M.D.
- Independent Director
- 41.00万
- Shantanu Narayen
- Lead Independent Director
- 43.00万
- Ronald E. Blaylock
- Independent Director
- 38.00万
- Joseph J. Echevarria
- Independent Director
- 39.00万
- Dr. Susan D. Desmond-Hellmann, M.D.,M.P.H.
- Independent Director
- 36.00万
- James Robert Quincey
- Independent Director
- 38.00万
- Dr. Scott Gottlieb,M.D.
- Independent Director
- 41.72万
- James C. Smith
- Independent Director
- 39.00万
美股市场投资机会
美股科技股 美股科技股
美股股票市场上受到广泛关注、具有显著行业影响力、市场表现活跃且市值规模较大的科技公司股票。显示的所有第三方徽标、品牌或商标仅用于识别目的，仍然是其各自所有者的财产。資訊由富途提供, 并非详尽无遗的有关主题概念股, 仅供参考。
展示条件: 美股科技股概念板块中涨跌幅首5位, 由高至低排列，实时市场数据。 美股股票市场上受到广泛关注、具有显著行业影响力、市场表现活跃且市值规模较大的科技公司股票。显示的所有第三方徽标、品牌或商标仅用于识别目的，仍然是其各自所有者的财产。資訊由富途提供, 并非详尽无遗的有关主题概念股, 仅供参考。
展示条件: 美股科技股概念板块中涨跌幅首5位, 由高至低排列，实时市场数据。
